Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC)

被引：0
|
作者：
Fernando Rivera
M. Eugenia Vega-Villegas
Marta López-Brea
Dolores Isla
Marta Mayorga
Piedad Galdós
Antonio Rubio
Adolfo Del Valle
Fe García-Reija
Belen García-Montesinos
Julio Rodríguez-Iglesias
Jose Mayordomo
Julio Rama
Ramón Saiz-Bustillo
Jaime Sanz-Ortiz
机构：
[1] Hospital Universitario Marqués de Valdecilla,Department of Medical Oncology
[2] Hospital Universitario Lozana Blesa,Department of Medical Oncology
[3] Hospital Universitario Marqués de Valdecilla,Department of Pathology
[4] Hospital Universitario Marqués de Valdecilla,Department of Radiotherapy
[5] Hospital Universitario Marqués de Valdecilla,Department of Otorrhinolaringology
[6] Hospital Universitario Marqués de Valdecilla,Department of Maxilofacial Surgery
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 62卷
关键词：
Overall Survival; Docetaxel; Vinorelbine; Induction Chemotherapy; Complete Response Rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：253 / 261
页数：8
相关论文
共 50 条
  • [1] Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC)
    Rivera, Fernando
    Eugenia Vega-Villegas, M.
    Lopez-Brea, Marta
    Isla, Dolores
    Mayorga, Marta
    Galdos, Piedad
    Rubio, Antonio
    Del Valle, Adolfo
    Garcia-Reija, Fe
    Garcia-Montesinos, Belen
    Rodriguez-Iglesias, Julio
    Mayordomo, Jose
    Rama, Julio
    Saiz-Bustillo, Ramon
    Sanz-Ortiz, Jaime
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (02) : 253 - 261
  • [2] Neo-adjuvant chemotherapy with IV cisplatin and continuous infusion (CI) 5-FU versus IV cisplatin, CI 5-FU and vinorelbine in locoregionally advanced head and neck cancer
    Mantovani, G
    Bianchi, A
    Curreli, L
    Ghiani, M
    Massa, E
    Proto, E
    DelGiacco, GS
    [J]. 10TH MEDITERRANEAN CONGRESS OF CHEMOTHERAPY, 1996, : 569 - 572
  • [3] Neoadyuvant chemotherapy with cisplatin (CDDP) plus 5-FU vs. cisplatin plus UFT in locally-advanced squamous head and neck cancer
    Carbonero, IG
    GonzalezLarriba, JL
    SastreValera, J
    PerezSegura, P
    DiazRubio, E
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 853 - 853
  • [4] LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMAS TREATED WITH DCF (DOCETAXEL, CISPLATIN, 5-FU) INDUCTION CHEMOTHERAPY
    Taguchi, J.
    Amano, T.
    Kinoshita, I.
    Honma, R.
    Shimizu, Y.
    Tsuchiya, K.
    Shirato, H.
    Homma, A.
    Fukuda, S.
    Akita, H.
    [J]. ANNALS OF ONCOLOGY, 2013, 24
  • [5] Locally advanced head and neck squamous cell carcinomas treated with TPF(docetaxel, cisplatin, 5-FU) induction chemotherapy
    Taguchi, Jun
    Shimizu, Yasushi
    Kinoshita, Ichiro
    Honma, Rio
    Takeuchi, Satoshi
    Tsuchiya, Kazuhiko
    Shirato, Hiroki
    Homma, Akihiro
    Fukuda, Satoshi
    Akita, Hirotoshi
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 90 - 90
  • [6] Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck:: A randomised phase II study
    Fonseca, E
    Grau, JJ
    Sastre, J
    García-Gómez, JM
    Rueda, A
    Pastor, M
    Lara, MA
    Navalón, M
    Berrocal, A
    Tisaire, JL
    Cruz, JJ
    [J]. EUROPEAN JOURNAL OF CANCER, 2005, 41 (09) : 1254 - 1260
  • [7] The Use of Low-dose Weekly Cisplatin with Concurrent Radiation Therapy in the Treatment of Locally Advanced Squamous Cell Head and Neck Cancer (LA-SCHNC)
    Ashton, S. N.
    Mix, M.
    Singh, A.
    Hicks, A. M.
    Gajra, A.
    Hsu, J.
    Hahn, S. S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S475 - S475
  • [8] Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial
    Keil, Felix
    Hartl, Maximilian
    Altorjai, Gabriela
    Berghold, Andrea
    Riedl, Regina
    Pecherstorfer, Martin
    Mayrbaeurl, Beate
    De Vries, Alexander
    Schuster, Judith
    Hackl, Jutta
    Fuereder, Thorsten
    Melchardt, Thomas
    Burian, Martin
    Greil, Richard
    [J]. EUROPEAN JOURNAL OF CANCER, 2021, 151 : 201 - 210
  • [9] Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
    Bleiberg, H
    Conroy, T
    Paillot, B
    Lacave, AJ
    Blijham, G
    Jacob, JH
    Bedenne, L
    Namer, M
    DeBesi, P
    Gay, F
    Collette, L
    Sahmoud, T
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1216 - 1220
  • [10] Phase II trial of vinorelbine, cisplatin and continuous infusion of 5-fluorouracil followed by hyperfractionated radiotherapy in locally advanced head and neck cancer
    Orecchia, R
    Jereczek-Fossa, BA
    Catalano, G
    Chiesa, F
    DePas, T
    Masci, G
    Krengli, M
    Vavassori, A
    De Paoli, F
    Robertson, C
    Marrocco, E
    De Braud, F
    [J]. ONCOLOGY, 2002, 63 (02) : 115 - 123
12345